Posted on Monday, 28 February 2011 by
PR Newswire: Biotechnology
HUDDINGE, Sweden, March 1, 2011 /PRNewswire-FirstCall/ -- Medivir AB
(OMX: MVIR), the emerging research-based specialty pharmaceutical company
focused on infectious diseases, today announces that the Company's
commercialization partner, Meda AB, has launched Medivir's unique cold sore
treatment
Read the full article at PR Newswire: Biotechnology